Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 506 entries
View as:

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

Phase: N/A Priority: Normal
NCT ID: NCT00440011 Org: User:
Start: 08/31/06 End: 10/31/07 Due: 10/31/08

Study of MAP0010 in Asthmatic Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00697801 Org: User:
Start: 07/31/06 End: 12/31/06 Due: 12/31/07

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02250651 Org: User:
Start: 12/15/14 End: 07/22/20 Due: 07/22/21

Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01229462 Org: User:
Start: 10/31/10 End: 09/30/11 Due: 09/30/12

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01298700 Org: User:
Start: 05/31/11 End: 12/06/16 Due: 12/06/17

Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00541242 Org: User:
Start: 12/31/07 End: 08/31/08 Due: 08/31/09

Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Phase: N/A Priority: Normal
NCT ID: NCT01608672 Org: User:
Start: 04/01/12 End: 12/31/12 Due: 12/31/13

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01637246 Org: User:
Start: 04/30/09 End: 11/30/11 Due: 11/30/12

BOTOX® Economic Spasticity Trial (BEST)

Phase: N/A Priority: Normal
NCT ID: NCT00549783 Org: User:
Start: 10/31/07 End: 07/31/10 Due: 07/31/11

Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®

Phase: N/A Priority: Normal
NCT ID: NCT02502123 Org: User:
Start: 07/02/15 End: 01/29/19 Due: 01/29/20

Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT00978042 Org: User:
Start: 08/31/09 End: 04/30/14 Due: 04/30/15

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03939312 Org: User:
Start: 05/06/19 End: 03/31/21 Due: 03/31/22

Phase 3 Study of MAP0004 in Adult Migraineurs

Phase: N/A Priority: Normal
NCT ID: NCT00623636 Org: User:
Start: 07/31/08 End: 01/31/11 Due: 01/31/12

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT00514852 Org: User:
Start: 10/31/07 End: 01/31/08 Due: 01/31/09

Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00693485 Org: User:
Start: 09/30/08 End: 08/31/11 Due: 08/31/12

Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients

Phase: N/A Priority: Normal
NCT ID: NCT00611403 Org: User:
Start: 12/31/07 End: 06/30/09 Due: 06/30/10

A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT03539549 Org: User:
Start: 05/25/18 End: 02/27/19 Due: 02/27/20

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01068964 Org: User:
Start: 02/01/10 End: 09/01/10 Due: 09/01/11

Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation

Phase: N/A Priority: Normal
NCT ID: NCT02910713 Org: User:
Start: 09/30/16 End: 10/31/16 Due: 10/31/17

Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT02965846 Org: User:
Start: 12/13/16 End: 06/13/17 Due: 06/13/18

Diabetic Gastroparesis Study 05

Phase: N/A Priority: Normal
NCT ID: NCT03786380 Org: User:
Start: 12/20/18 End: 10/05/20 Due: 10/05/21

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01492400 Org: User:
Start: 03/09/12 End: 02/13/14 Due: 02/13/15

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

Phase: N/A Priority: Normal
NCT ID: NCT02188173 Org: User:
Start: 07/31/14 End: 05/31/16 Due: 05/31/17

Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02462486 Org: User:
Start: 06/25/15 End: 06/06/19 Due: 06/06/20

Optive Brand For Day And Night Dry Eye Management

Phase: N/A Priority: Normal
NCT ID: NCT03208673 Org: User:
Start: 07/03/17 End: 09/06/17 Due: 09/06/18